The January 28 meeting with the new IRB, at which Dr. Michael Mithoefer and Rick Doblin, Ph.D. appeared in person, involved a series of thoughtful questions about protocol design, risk assessment, confidentiality procedures and the nature of PTSD and currently available treatments. The meeting was characterized by mutual respect. We expect to receive a written report outlining the IRB’s decisions within the next several weeks.